Description

• A blend of Tesamorelin (10mg) and Ipamorelin (5mg) studied for its role in stimulating growth hormone (GH) release.
• Tesamorelin, a growth hormone-releasing factor (GHRF) analog, has been researched for its effects on GH production and lipid metabolism.
• Ipamorelin interacts with the ghrelin receptor, influencing GH release while minimizing interactions with other endocrine pathways.
• This combination has been explored for its potential impact on metabolic processes and tissue studies.
• Commonly utilized in controlled research settings to evaluate GH-related responses.